Serum Endocan Levels in Patients with Stable COPD

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2018 Nov 10

PMID 30410323

Citations 5

Authors

Aylin Pihtili

Zuleyha Bingol

Esen Kiyan

Affiliations

Soon will be listed here.

Abstract

Background: Endothelial cell specific molecule-1, also called as endocan, is a dermatan sulfate proteoglycan, which is expressed by endothelial cells in alveolar walls of the lung and kidney. High endocan levels are found associated with endothelial dysfunction and inflammation. We hypothesize that endocan level is also high in COPD due to systemic inflammation and endothelial dysfunction. We aimed to investigate the expression of endocan in patients with stable COPD.

Material And Methods: The study included patients with COPD and control subjects. COPD patients were classified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 criteria. Demographics, body mass index, smoking history, and comorbidities were recorded. Endocan levels of COPD patients and controls were compared.

Results: Totally, 88 subjects (47 stable COPD patients, 41 controls) were evaluated. Endocan levels were significantly higher in COPD patients than control group (860.1±259.8 vs 647.3±316.9 pg/mL, =0.001). There was no relationship between GOLD COPD categories and endocan levels. Also endocan levels were similar between COPD patients with or without hypoxemia.

Conclusion: Serum endocan level was significantly higher in patients with stable COPD. Further studies should be performed to better understand the relationship between endocan and COPD.

Citing Articles

Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.

Caird R, Williamson M, Yusuf A, Gogoi D, Casey M, McElvaney N Int J Mol Sci. 2022; 23(12).

PMID: 35742845 PMC: 9224208. DOI: 10.3390/ijms23126400.

Identifying miRNA Modules and Related Pathways of Chronic Obstructive Pulmonary Disease Associated Emphysema by Weighted Gene Co-Expression Network Analysis.

An J, Yang T, Dong J, Liao Z, Wan C, Shen Y Int J Chron Obstruct Pulmon Dis. 2021; 16:3119-3130.

PMID: 34815668 PMC: 8605490. DOI: 10.2147/COPD.S325300.

Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders.

Amendum P, Khan S, Yamaguchi S, Kobayashi H, Ago Y, Suzuki Y Diagnostics (Basel). 2021; 11(9).

PMID: 34573906 PMC: 8468223. DOI: 10.3390/diagnostics11091563.

Decreased expression of endothelial cell specific molecule-1 in lung tissue in emphysematous mice and stable COPD patients.

Zhang Y, Chen P, Cai S, Li J, Chen Y Iran J Basic Med Sci. 2021; 23(12):1610-1617.

PMID: 33489036 PMC: 7811818. DOI: 10.22038/ijbms.2020.44243.10384.

Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.

Wu Y, Qin J, He J, Shen Y, Wang H, Li Y Int J Chron Obstruct Pulmon Dis. 2020; 15:397-407.

PMID: 32158205 PMC: 7049271. DOI: 10.2147/COPD.S234760.

References

Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R . Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2012; 73(3):1097-106. DOI: 10.1158/0008-5472.CAN-12-1855. View

Aitkenhead M, Wang S, Nakatsu M, Mestas J, Heard C, Hughes C . Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM. Microvasc Res. 2002; 63(2):159-71. DOI: 10.1006/mvre.2001.2380. View

Balta I, Balta S, Mustu Koryurek O, Demirkol S, Mikhailidis D, Celik T . Serum endocan levels as a marker of disease activity in patients with Behçet disease. J Am Acad Dermatol. 2013; 70(2):291-6. DOI: 10.1016/j.jaad.2013.09.013. View

Kim H, Kim B, Park R, Yoon K, Jeong E, Hwang K . Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion. Tohoku J Exp Med. 2017; 242(2):137-142. DOI: 10.1620/tjem.242.137. View

Miller J, Edwards L, Agusti A, Bakke P, Calverley P, Celli B . Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013; 107(9):1376-84. DOI: 10.1016/j.rmed.2013.05.001. View

Keatings V, Collins P, Scott D, Barnes P . Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996; 153(2):530-4. DOI: 10.1164/ajrccm.153.2.8564092. View

Schuitemaker J, Cremers T, van Pampus M, Scherjon S, Faas M . Changes in endothelial cell specific molecule 1 plasma levels during preeclamptic pregnancies compared to healthy pregnancies. Pregnancy Hypertens. 2018; 12:58-64. DOI: 10.1016/j.preghy.2018.02.012. View

Lu G, Shao C, Zhang Y, Wei Y, Xie W, Kong H . Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer. Oncotarget. 2017; 8(30):49217-49223. PMC: 5564762. DOI: 10.18632/oncotarget.17455. View

Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T . Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006; 34(2):532-7. DOI: 10.1097/01.ccm.0000198525.82124.74. View

10.

Bechard D, Meignin V, Scherpereel A, Oudin S, Kervoaze G, Bertheau P . Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res. 2000; 37(5):417-25. DOI: 10.1159/000025758. View

11.

Kechagia M, Papassotiriou I, Gourgoulianis K . Endocan and the respiratory system: a review. Int J Chron Obstruct Pulmon Dis. 2016; 11():3179-3187. PMC: 5161333. DOI: 10.2147/COPD.S118692. View

12.

Bechard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M . Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 2001; 276(51):48341-9. DOI: 10.1074/jbc.M108395200. View

13.

Grigoriu B, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T . Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res. 2006; 12(15):4575-82. DOI: 10.1158/1078-0432.CCR-06-0185. View

14.

Kao S, Chuang C, Tang C, Lin C, Bien M, Yu M . Plasma endothelial cell-specific molecule-1 (ESM-1) in management of community-acquired pneumonia. Clin Chem Lab Med. 2013; 52(3):445-51. DOI: 10.1515/cclm-2013-0638. View

15.

LIEBOW A . Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis. 1959; 80(1, Part 2):67-93. DOI: 10.1164/arrd.1959.80.1P2.67. View

16.

Peinado V, Barbera J, Ramirez J, Gomez F, Roca J, Jover L . Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998; 274(6):L908-13. DOI: 10.1152/ajplung.1998.274.6.L908. View

17.

Mikkelsen M, Shah C, Scherpereel A, Lanken P, Lassalle P, Bellamy S . Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care. 2011; 27(5):522.e11-7. PMC: 3790584. DOI: 10.1016/j.jcrc.2011.07.077. View

18.

Tang L, Zhao Y, Wang D, Deng W, Li C, Li Q . Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Mediators Inflamm. 2014; 2014:625180. PMC: 4124235. DOI: 10.1155/2014/625180. View

19.

Balta S, Mikhailidis D, Demirkol S, Ozturk C, Kurtoglu E, Demir M . Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology. 2014; 65(9):773-7. DOI: 10.1177/0003319713513492. View

20.

Polverino F, Celli B, Owen C . COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm Circ. 2018; 8(1):2045894018758528. PMC: 5826015. DOI: 10.1177/2045894018758528. View